MetinOzdemirliMD

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, Georgetown University Hospital

Are you Dr. Ozdemirli?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Metin Ozdemirli, MD is a board certified pathologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia and Maryland. He is affiliated with MedStar Georgetown University Hospital and is a Professor at Georgetown University Hospital.

Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1995
Boston University School of MedicineClass of 1993

PubMed

40 citations
Ezrin Inhibition Up-regulates Stress Response Gene Expression.
Haydar Çelik, Gülay Bulut, Jenny Han, Garrett T. Graham, Tsion Z. Minas
The Journal of Biological Chemistry. 2016-06-17
3 citations
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.
Metin Ozdemirli, Thomas M Loughney, Emre Deniz, Joeffrey J Chahine, Maher Albitar
The New England Journal of Medicine. 2024-06-13
265 citations
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp, Lymor Ringer, Gülay Bulut, Kamal P. Sajwan, Michael D. Hall
The Journal of Clinical Investigation. 2011-01-04

Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T TherapyJune 13th, 2024
Tragic New Details About Dozens of American Patients Whose Life-Saving Cancer Treatment Caused Them to Develop More CancersJune 13th, 2024
Immunotherapy to Treat Cancer Gave Rise to 2nd Cancer in Extremely Rare CaseJune 14th, 2024
Join now to see all